Correction of coagulopathy for percutaneous interventions

Charles Wiltrout, Kimi L. Kondo

Research output: Contribution to journalArticle

Abstract

Due to medical illness or pharmacotherapy, patients undergoing percutaneous interventions often have abnormal hemostasis. Its etiology may include alterations in the protein-based coagulation system, thrombocytopenia, deficient platelet function, or mixed deficits such as disseminated intravascular coagulation. In this article, the authors review the basic science of each of these etiologies, as well as their available methods of correction. They also review the evidence and guidelines regarding the assessment and treatment of coagulopathy in image-guided procedures. The periprocedural bleeding risk and the urgency of a given procedure guide the management of abnormal hemostasis in this patient population.

Original languageEnglish (US)
Pages (from-to)338-347
Number of pages10
JournalSeminars in Interventional Radiology
Volume27
Issue number4
DOIs
StatePublished - Nov 22 2010

Keywords

  • Anticoagulation
  • Coagulopathy
  • Disseminated intravascular coagulation
  • Platelets
  • Reversal

Fingerprint Dive into the research topics of 'Correction of coagulopathy for percutaneous interventions'. Together they form a unique fingerprint.

Cite this